Anglo-Eastern Plantations

AEP · Main Market · Food, Beverage and Tobacco · mcap £747m · 177.4p

Beta Briefing, track record and signals & risks are not ready for Anglo-Eastern Plantations yet.

We follow 964 UK small caps and every one of their announcements – often hundreds per company. 73 companies are already wired into a briefing: browse them.

Financials · balance sheet 30 Jun 26 · last twelve months · today’s market value

Source: results 02 Sep 26 ↗

Key figures Cash & debt Profit & cash flow Valuation Returns & quality Latest half-year

Market cap: £680.5m
Owner’s net cash: £66.5m
Net cash / market cap: 10%
EV ex leases: £619.6m
Revenue: £360.9m
Operating profit: £85.5m
Free cash flow after leases: £39.8m
EV / EBIT: 7.2×
FCF yield: 5.8%
Price / tangible book: 1.56×
ROCE: 18%
Net income (owners): £67.8m

Hover or tap a figure for its formula and the values used – the names are the line names of the key figures below. Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

Key figures As reported

Income statement Balance sheet Cash flow

Annual Half-yearly

Standardised line items in £m, comparable across companies – figures the company reported in USD are converted to £ at the average rate of each period (balance sheets: at the date); when a later report restated a period, the later figure is shown and marked ^r (hover for the figure first reported). Italic = calculated (LTM, H2 = FY − H1); a year of other than 12 months is marked (15m). Hover a value for its source.

Trading update 12 Oct 266 figures since the last report

9m 2026 production up 13-18%, interim dividend declared at 3.73 cents per share, ninth mill on track for January 2027.

Own FFB production (9m 2026)	924,500 mt	816,200 mt
CPO production (9m 2026)	379,200 mt	321,600 mt
PK production (9m 2026)	93,100 mt	79,600 mt
Net cash (30 Sept 2026)	$99.0 million	$232.3 million
Interim dividend	3.73 cents per share
Average CPO Ex-mill price	$/mt 855	$/mt 855

As stated by the company, unaudited. Read it →

Latest report: H1 26 (six months to 30 Jun 26), published 02 Sep 26 · read the results ↗

Source ↗

	2026 6 months to 30 June (unaudited) $000	2025 6 months to 30 June (unaudited) $000	2025 Year to 31 December (audited) $000
Revenue	249,728	230,466	465,211
Cost of sales	(189,495)	(168,043)	(339,982)
Changes in fair value of biological assets	2,610	416	(1,408)
Gross profit	62,843	62,839	123,821
Administration expenses	(10,457)	(4,699)	(14,186)
Other income	1,089	732	1,315
Gain on bargain purchase	9,062	-	-
Reversal of impairment loss	-	-	710
(Loss)/gain arising from fair value of investments	(4)	297	(107)
Operating profit	62,533	59,169	111,553
Exchange gains/(loss)	834	266	(176)
Finance income	2,657	3,141	7,997
Finance expense	(190)	(25)	(44)
Profit before tax	65,834	62,551	119,330
Tax expense	(16,911)	(13,748)	(33,015)
Profit for the period	48,923	48,803	86,315
Profit for the period attributable to
- Owners of the parent	48,981	48,660	90,882
- Non-controlling interests	(58)	143	(4,567)
Total profit for the period attributable to	48,923	48,803	86,315

Source ↗

	2026 as at 30 June (unaudited) $000	2025 as at 30 June (unaudited) $000	2025 as at 31 December (audited) $000
Non-current assets
Property, plant and equipment	451,825	272,276	272,547
Intangible assets	680	-	262
Investments in associates	1	-	1
Investments	41	9,405	45
Receivables	19,909	21,007	17,800
Deferred tax assets	513	1,991	974
Defined benefit assets	1,875	-	-
Total non-current assets	474,844	304,679	291,629
Current assets
Inventories	44,826	23,604	27,652
Income tax receivables	5,562	18,316	4,992
Other tax receivables	34,679	29,002	41,863
Biological assets	9,862	8,448	6,383
Trade and other receivables	11,821	8,078	9,045
Investments	4,000	18,000	22,000
Short-term investments	-	-	500
Cash and cash equivalents	109,511	244,697	231,845
Total current assets	220,261	350,145	344,280
Total assets	695,105	654,824	635,909
Current liabilities
Bank loans	(8,681)	-	-
Trade and other payables	(39,130)	(27,118)	(28,356)
Income tax liabilities	(5,993)	(5,466)	(10,173)
Other tax liabilities	(4,187)	(3,142)	(814)
Dividend payables	(16,826)	(20,137)	(65)
Lease liabilities	(324)	(249)	(202)
Total current liabilities	(75,141)	(56,112)	(39,610)
Net current assets	145,120	294,033	304,670
	2026	2025	2025
as at 30 June as at 30 June as at 31 December
(unaudited) (unaudited) (audited)
Total (unaudited) (unaudited) (audited)	$000	$000	$000
Non-current liabilities
Bank loans	(4,533)	-	-
Deferred tax liabilities	(27,280)	(2,401)	(3,062)
Retirement benefits - net liabilities	(8,198)	(11,168)	(7,972)
Lease liabilities	(542)	(392)	(338)
Total non-current liabilities	(40,553)	(13,961)	(11,372)
Net assets	579,411	584,751	584,927
Issued capital and reserves attributable to owners of the parent
Share capital	15,504	15,504	15,504
Treasury shares	(22,951)	(3,368)	(13,840)
Share premium	23,935	23,935	23,935
Capital redemption reserve	1,087	1,087	1,087
Exchange reserves	(413,458)	(366,165)	(381,476)
Retained earnings	967,846	905,963	935,479
Total issued capital and reserves attributable to owners of the parent	571,963	576,956	580,689
Non-controlling interests	7,448	7,795	4,238
Total equity	579,411	584,751	584,927

Source ↗

	2026 6 months to 30 June (unaudited) $000	2025 6 months to 30 June (unaudited) $000	2025 Year to 31 December (audited) $000
Cash flows from operating activities
Profit before tax	65,834	62,551	119,330
Adjustments for
Changes in fair value of biological assets	(2,610)	(416)	1,408
Gain on disposal of property, plant and equipment	(17)	(68)	(95)
Depreciation	12,378	9,226	18,958
Retirement benefit provisions	913	1,020	2,247
Finance income	(2,657)	(3,141)	(7,997)
Finance expense	190	25	44
Unrealised gain in foreign exchange	(10)	(58)	(23)
Loss/(gain) arising from fair value	4	(297)	107
Property, plant and equipment written off	433	-	904
Reversal of impairment loss	-	-	(710)
(Reversal)/provision for expected credit loss	(101)	4	(85)
Gain on bargain purchase	(9,062)	-	-
Operating cash flows before changes in working capital	65,295	68,846	134,088
Increase in inventories	(10,697)	(4,857)	(9,749)
Increase in non-current, trade and other receivables	(5,737)	(3,889)	(1,499)
Increase in trade and other payables	7,780	5,826	7,503
Cash inflows from operations	56,641	65,926	130,343
Retirement benefits paid	(465)	(881)	(2,615)
Overseas tax (paid)/refund	(14,478)	2,601	(13,903)
Net cash generated from operating activities	41,698	67,646	113,825
	2026	2025	2025
6 months 6 months Year
to 30 June to 30 June to 31 December
(unaudited) (unaudited) (audited)
Total (unaudited) (unaudited) (audited)	$000	$000	$000
Investing activities
Acquisition of new subsidiaries	(158,342)	-	-
Cash and cash equivalents acquired on acquisition	2,837	-	-
Acquisition of associates	-	-	(1)
Property, plant and equipment
- purchases	(14,648)	(11,238)	(29,922)
- sale proceeds	69	228	325
Intangible asset
- purchases	(450)	-	(262)
Interest received	2,657	3,141	7,997
Additions to receivables from cooperatives under Plasma scheme	(159)	(382)	(2,181)
Repayment from cooperatives under Plasma scheme	280	915	3,110
Investment in investment portfolio	-	(30,018)	(29,068)
Disposal of investment portfolio	18,000	31,997	36,003
Placement of fixed deposits with original maturity of more than three months	-	-	(500)
Withdrawal of fixed deposits with original maturity of more than three months	500	1,253	1,253
Net cash used in investing activities	(149,256)	(4,104)	(13,246)
Financing activities
Dividends paid to the holders of the parent	(2)	-	(34,630)
Repayment of lease liabilities - principal	(186)	(155)	(321)
Repayment of lease liabilities - interest	(23)	(25)	(44)
Repayment of bank loans	(114)	-	-
Share buy back	(9,111)	(881)	(11,353)
Net cash used in financing activities	(9,436)	(1,061)	(46,348)
Net (decrease)/increase in cash and cash equivalents	(116,994)	62,481	54,231
Cash and cash equivalents
At beginning of period	231,845	181,908	181,908
Exchange (loss)/gain	(5,340)	308	(4,294)
At end of period	109,511	244,697	231,845
Comprising
Cash at end of period	109,511	244,697	231,845

Source ↗

	2025 $000	2024 $000
Continuing operations
Revenue	465,211	372,263
Cost of sales	(339,982)	(286,583)
Changes in fair value of biological assets	(1,408)	2,942
Gross profit	123,821	88,622
Administration expenses	(14,186)	(9,360)
Other income	1,315	1,474
Reversal of impairment/(impairment loss)	710	(133)
(Loss)/gain arising from fair value of investments	(107)	1,131
Operating profit	111,553	81,734
Exchange (loss)/ gains	(176)	1,056
Finance income	7,997	5,365
Finance expense	(44)	(65)
Profit before tax	119,330	88,090
Tax expense	(33,015)	(20,478)
Profit for the year	86,315	67,612
Profit/(loss) for the year attributable to
- Owners of the parent	90,882	67,514
- Non-controlling interests	(4,567)	98
Total profit/(loss) for the year attributable to	86,315	67,612

Source ↗

	31.12.2025 $000	31.12.2024 $000
Non-current assets
Property, plant and equipment	272,547	271,170
Intangible assets	262	-
Investments in associates	1	-
Investments	45	5,111
Receivables	17,800	19,363
Deferred tax assets	974	1,900
Total non-current assets	291,629	297,544
Current assets
Inventories	27,652	18,767
Income tax receivables	4,992	18,316
Other tax receivables	41,863	43,749
Biological assets	6,383	8,057
Trade and other receivables	9,045	7,062
Investments	22,000	23,976
Short-term investments	500	1,253
Cash and cash equivalents	231,845	181,908
Total current assets	344,280	303,088
Current liabilities
Trade and other payables	(28,356)	(21,403)
Income tax liabilities	(10,173)	(5,466)
Other tax liabilities	(814)	(1,201)
Dividend payables	(65)	(46)
Lease liabilities	(202)	(307)
Total current liabilities	(39,610)	(28,423)
Net current assets	304,670	274,665
Non-current liabilities
Deferred tax liabilities	(3,062)	(2,225)
Retirement benefits - net liabilities	(7,972)	(11,073)
Lease liabilities	(338)	(453)
Total non-current liabilities	(11,372)	(13,751)
Net assets	584,927	558,458

Source ↗

	2025 $000	2024 $000
Cash flows from operating activities
Profit before tax	119,330	88,090
Adjustments for
Changes in fair value of biological assets	1,408	(2,942)
Gain on disposal of property, plant and equipment	(95)	(380)
Depreciation	18,958	18,986
Retirement benefit provisions	2,247	2,764
Finance income	(7,997)	(5,365)
Finance expense	44	65
Unrealised (gain)/loss in foreign exchange	(23)	31
Loss/(gain) arising from fair value	107	(1,131)
Property, plant and equipment written off	904	451
(Reversal of impairment)/impairment loss	(710)	133
Reversal for expected credit loss	(85)	(9)
Operating cash flows before changes in working capital	134,088	100,693
Increase in inventories	(9,749)	(2,907)
(Increase)/Decrease in non-current, trade and other receivables	(1,499)	5,588
Increase/(Decrease) in trade and other payables	7,503	(5,059)
Cash inflows from operations	130,343	98,315
Retirement benefits paid	(2,615)	(1,984)
Overseas tax paid	(13,903)	(22,384)
Net cash generated from operating activities	113,825	73,947
Investing activities
Acquisition of associates	(1)	-
Property, plant and equipment
- purchases	(29,922)	(29,013)
- sale proceeds	325	872
Intangible assets
- purchases	(262)	-
Interest received	7,997	5,365
Additions to receivables from cooperatives under plasma scheme	(2,181)	(5,010)
Repayment from cooperatives under plasma scheme	3,110	2,689
Investment in investment portfolio or bond portfolio	(29,068)	(45,990)
Disposal of investment portfolio	36,003	28,069
Placement of fixed deposits with original maturity of more than three months	(500)	(1,253)
Withdrawal of fixed deposits with original maturity of more than three months	1,253	14,076
Net cash used in investing activities	(13,246)	(30,195)
	2025	2024
Note	$000	$000
Financing activities Dividends paid to the holders of the parent	(34,630)	(5,918)
Repayment of lease liabilities - principal	(321)	(340)
Repayment of lease liabilities - interest	(44)	(65)
Acquisition of non-controlling interests	-	(400)
Share buy back	(11,353)	(640)
Net cash used in financing activities	(46,348)	(7,363)
Net increase in cash and cash equivalents	54,231	36,389
Cash and cash equivalents At beginning of year	181,908	152,984
Exchange losses	(4,294)	(7,465)
At end of year	231,845	181,908
Comprising
Cash at end of year	231,845	181,908

	LTM Jun 26	FY 25
Revenue to operating profit
Revenue	360.9	353.1
Gross profit	92.2	94.0
Operating profit	85.5	84.7
Operating profit to net income
Fair value gains / losses	(0.3)	(0.1)
Finance costs	(0.2)	(0.0)
Profit before tax	91.2	90.6
Tax	(27.0)	(25.1)
Net income (owners)	67.8	69.0
Per share
EPS basic	17.8p	17.2p
EPS diluted	17.8p	17.2p

	H1 26	vs H1 25	H2 25	H1 25
Revenue to operating profit
Revenue	185.7	+4%	175.2	177.9
Gross profit	46.7	−4%	45.5	48.5
Operating profit	46.5	+2%	39.0	45.7
Operating profit to net income
Fair value gains / losses	(0.0)	n/m	(0.3)	0.2
Finance costs	(0.1)	n/m	(0.0)	(0.0)
Profit before tax	49.0	+1%	42.3	48.3
Tax	(12.6)	+18%	(14.4)	(10.6)
Net income (owners)	36.4	−3%	31.4	37.6
Per share
EPS basic	9.6p	–	8.2p	9.0p
EPS diluted	9.6p	–	8.2p	9.0p

	LTM Jun 26	FY 25
Operating activities
Cash from operations	65.2	86.4
Tax paid	(23.3)	(10.6)
Investing activities
Capex (PP&E)	(24.9)	(22.7)
Capex (intangibles)	–	(0.2)
Financing activities
Lease principal paid	(0.3)	(0.2)
Lease interest paid	(0.0)	(0.0)
Dividends paid	–	(26.3)
Share buybacks	(14.7)	(8.6)

	H1 26	vs H1 25	H2 25	H1 25
Operating activities
Cash from operations	31.0	−41%	34.2	52.2
Tax paid	(10.8)	n/m	(12.6)	2.0
Investing activities
Capex (PP&E)	(10.9)	+26%	(14.0)	(8.7)
Capex (intangibles)	(0.3)	–	–	–
Financing activities
Lease principal paid	(0.1)	+16%	(0.1)	(0.1)
Lease interest paid	(0.0)	n/m	(0.0)	(0.0)
Dividends paid	(0.0)	–	–	–
Share buybacks	(6.8)	n/m	(7.9)	(0.7)

	30 Jun 26	31 Dec 25
Non-current assets
Other intangibles	0.5	0.2
Property, plant & equipment	340.9	202.4
Associates & JVs	0.0	0.0
Non-current assets	358.3	216.5
Current assets
Inventories	33.8	20.5
Trade receivables	8.9	6.7
Cash	82.6	172.2
Current assets	166.2	255.6
Total assets	524.4	472.2
Current liabilities
Trade payables	29.5	21.1
Borrowings, current	6.5	–
Lease liabilities, current	0.2	0.1
Current liabilities	56.7	29.4
Non-current liabilities
Borrowings, non-current	3.4	–
Lease liabilities, non-current	0.4	0.3
Pension surplus / (deficit)	(6.2)	(5.9)
Equity
Non-controlling interests	5.6	3.1
Total equity	437.2	434.3
Net cash and other figures
Treasury shares	-23.0m	-13.8m

	30 Jun 26	31 Dec 25	30 Jun 25
Non-current assets
Other intangibles	0.5	0.2	–
Property, plant & equipment	340.9	202.4	198.5
Associates & JVs	0.0	0.0	–
Non-current assets	358.3	216.5	222.1
Current assets
Inventories	33.8	20.5	17.2
Trade receivables	8.9	6.7	5.9
Cash	82.6	172.2	178.4
Current assets	166.2	255.6	255.2
Total assets	524.4	472.2	477.3
Current liabilities
Trade payables	29.5	21.1	19.8
Borrowings, current	6.5	–	–
Lease liabilities, current	0.2	0.1	0.2
Current liabilities	56.7	29.4	40.9
Non-current liabilities
Borrowings, non-current	3.4	–	–
Lease liabilities, non-current	0.4	0.3	0.3
Pension surplus / (deficit)	(6.2)	(5.9)	(8.1)
Equity
Non-controlling interests	5.6	3.1	5.7
Total equity	437.2	434.3	426.2
Net cash and other figures
Treasury shares	-23.0m	-13.8m	-3.4m

Read automatically from each results announcement. Check the source before relying on a figure.

Spotted an error in this income statement? Report it

Company filings. Not investment advice.